Ipsen SA Cash Flow Conversion Efficiency

Latest as of June 2025: 0.125x

Ipsen SA cash flow conversion efficiency. Based on the latest financial reports, Ipsen SA (IPN) has a cash flow conversion efficiency ratio of 0.125x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€526.70 Million ≈ $615.77 Million USD) by net assets (€4.23 Billion ≈ $4.95 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Ipsen SA (2002–2024)

Cash flow conversion efficiency of Ipsen SA from 2002 to 2024. This chart illustrates how Ipsen SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Ipsen SA for real-time trading data and today's change.

Ipsen SA Cash Flow Conversion Ratio Explained

Ipsen SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Ipsen SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ipsen SA ranked by their cash flow conversion efficiency. Also see how much is Ipsen SA worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Klepierre SA PA:LI	0.041x
APA Group AU:APA	0.250x
RAKUTEN GROUP SPONS.ADR 1 F:RAKA	0.382x
Industrial Bank Of Korea KO:024110	0.054x
Ambuja Cements Limited NSE:AMBUJACEM	0.020x
Sichuan Kelun Pharmaceutical Co Ltd SHE:002422	0.018x
Insurance Australia Group Limited F:NRM	0.010x
Hensoldt AG F:HAG	0.021x

Annual Cash Flow Conversion Efficiency for Ipsen SA (2002–2024)

The table below shows the annual cash flow conversion efficiency of Ipsen SA from 2002 to 2024. Review Ipsen SA free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€4.18 Billion ≈ $4.89 Billion	€915.50 Million ≈ $1.07 Billion	0.219x	-3.32%
2023-12-31	€3.82 Billion ≈ $4.47 Billion	€865.90 Million ≈ $1.01 Billion	0.226x	-22.22%
2022-12-31	€3.34 Billion ≈ $3.90 Billion	€971.40 Million ≈ $1.14 Billion	0.291x	-12.34%
2021-12-31	€2.74 Billion ≈ $3.20 Billion	€909.20 Million ≈ $1.06 Billion	0.332x	-8.12%
2020-12-31	€2.13 Billion ≈ $2.49 Billion	€771.30 Million ≈ $901.73 Million	0.361x	+0.94%
2019-12-31	€1.75 Billion ≈ $2.05 Billion	€627.70 Million ≈ $733.85 Million	0.358x	+15.62%
2018-12-31	€1.84 Billion ≈ $2.16 Billion	€570.90 Million ≈ $667.44 Million	0.310x	+12.48%
2017-12-31	€1.54 Billion ≈ $1.80 Billion	€422.90 Million ≈ $494.41 Million	0.275x	+18.02%
2016-12-31	€1.36 Billion ≈ $1.59 Billion	€317.80 Million ≈ $371.54 Million	0.233x	+27.88%
2015-12-31	€1.23 Billion ≈ $1.43 Billion	€223.60 Million ≈ $261.41 Million	0.182x	-20.74%
2014-12-31	€1.07 Billion ≈ $1.25 Billion	€245.80 Million ≈ $287.37 Million	0.230x	+19.15%
2013-12-31	€973.70 Million ≈ $1.14 Billion	€188.10 Million ≈ $219.91 Million	0.193x	+24.07%
2012-12-31	€926.25 Million ≈ $1.08 Billion	€144.22 Million ≈ $168.61 Million	0.156x	-9.89%
2011-12-31	€1.02 Billion ≈ $1.19 Billion	€175.45 Million ≈ $205.11 Million	0.173x	-26.56%
2010-12-31	€1.08 Billion ≈ $1.26 Billion	€253.91 Million ≈ $296.85 Million	0.235x	-10.11%
2009-12-31	€984.35 Million ≈ $1.15 Billion	€257.62 Million ≈ $301.19 Million	0.262x	+11.75%
2008-12-31	€868.49 Million ≈ $1.02 Billion	€203.41 Million ≈ $237.81 Million	0.234x	+6.63%
2007-12-31	€801.11 Million ≈ $936.58 Million	€175.97 Million ≈ $205.73 Million	0.220x	-51.20%
2006-12-31	€727.90 Million ≈ $851.00 Million	€327.63 Million ≈ $383.04 Million	0.450x	+86.93%
2005-12-31	€621.10 Million ≈ $726.13 Million	€149.55 Million ≈ $174.84 Million	0.241x	-44.79%
2004-12-31	€197.73 Million ≈ $231.17 Million	€86.23 Million ≈ $100.82 Million	0.436x	-10.31%
2003-12-31	€311.65 Million ≈ $364.36 Million	€151.54 Million ≈ $177.17 Million	0.486x	+18.78%
2002-12-31	€227.95 Million ≈ $266.50 Million	€93.32 Million ≈ $109.10 Million	0.409x	--

About Ipsen SA

PA:IPN France Drug Manufacturers - Specialty & Generic

Market Cap

$15.29 Billion

€13.07 Billion EUR

Market Cap Rank

#2080 Global

#44 in France

Share Price

€158.70

Change (1 day)

-0.44%

52-Week Range

€116.10 - €172.90

All Time High

€172.90